Results 101 to 110 of about 4,617,382 (195)
Introduction: Cerebral Infarction due to Severe ADAMTS-13 Deficiency (CISAD) remains an underrecognized cause of cryptogenic stroke. Despite the absence of classic hematologic features, CISAD confers a risk of recurrent ischemic events if not promptly ...
Johanna Seiden, MD, MPH +8 more
doaj +1 more source
Objective: to study the role of a tissue factor pathway inhibitor (TFPI), the metalloproteinase ADAMTS-13, and its inhibitor in the pathogenesis of acute respiratory distress syndrome (ARDS) in A/H1N1 influenza. Subjects and methods.
E. V. Prutkina +4 more
doaj +1 more source
Absence of Pro475Ser polymorphism in ADAMTS‐13 in Caucasians [PDF]
Bongers, TN +4 more
openaire +3 more sources
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by recurrent thrombosis and fetal mortality. Thrombotic microangiopathy (TMA) is an important histological finding in catastrophic APS (CAPS) and in APS patients with nephropathy. Analysis of familial thrombotic throm-bocytopenic purpura patients showed that there are mutations in ...
TOPAL SARIKAYA, AYŞEGÜL +2 more
openaire +1 more source
The relationship between coronary collateral circulation and ADAMTS-1 and ADAMTS-13 levels in ischemic heart patients [PDF]
Tıp Fakültesi, Tıbbi Biyokimya Ana Bilim Dalı, Tıbbi Biyoloji Bilim DalıGiriş ve Amaç: Koroner kollateral dolaşım, koroner arter hastalığının seyrinde ve prognozunda rol alan çok önemli bir klinik antitedir.
Gül, Abdülhakim Hasan
core +1 more source
OBJECTIVE: To analyze the preoperative plasma antigenic concentration and activity of von Willebrand factor and its main cleaving protease ADAMTS-13 in pediatric patients with cyanotic congenital heart disease undergoing surgical treatment and ...
Rosangela P.S. Soares +4 more
doaj
Investigation of ADAMTS-13 levels in patients with COVID-19 infection
Introduction: Coronavirus disease 2019 (COVID-19) patients are predisposed to thrombotic events. COVID-19 coagulopathy can be associated with ADAMTS-13 (a disintegrin-like and metalloprotease with thrombospondin type I repeats 13) levels. ADAMTS-13, the
Hüseyin H Kutlu +6 more
doaj +1 more source
Comparison of assays to evaluate ADAMTS13 activity in patients’ plasma
BACKGROUND : several assays for measurement of ADAMTS-13 activity have been developed. Although the performance characteristics of these methods were recently evaluated (Tripodi A, et al.
C. Valsecchi +5 more
core +2 more sources
Background: Management of patients with refractory or frequently relapsing (r/r) immune thrombotic thrombocytopenic purpura (iTTP) remains challenging, with no established consensus on optimal therapeutic strategies.
Roman Schimmer +6 more
doaj +1 more source
ADAMTS-13 is crucial for maintaining the normal size of vWF. Besides thrombotic thrombocytopenic purpura (TTP), decreased ADAMTS-13 had also been reported in patients with malignancy.
Zhao, Jingzhong +5 more
core +1 more source

